AstraZeneca PLC
LSE:AZN
AstraZeneca PLC
Common Stock
AstraZeneca PLC
Common Stock Peer Comparison
Competitive Common Stock Analysis
Latest Figures & CAGR of Competitors
Company | Common Stock | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
AstraZeneca PLC
LSE:AZN
|
Common Stock
$388m
|
CAGR 3-Years
6%
|
CAGR 5-Years
4%
|
CAGR 10-Years
2%
|
|
GlaxoSmithKline PLC
LSE:GSK
|
Common Stock
£1.3B
|
CAGR 3-Years
0%
|
CAGR 5-Years
0%
|
CAGR 10-Years
0%
|
|
Verona Pharma PLC
NASDAQ:VRNA
|
Common Stock
$42.8m
|
CAGR 3-Years
10%
|
CAGR 5-Years
45%
|
CAGR 10-Years
N/A
|
|
Indivior PLC
LSE:INDV
|
Common Stock
$68m
|
CAGR 3-Years
-2%
|
CAGR 5-Years
-1%
|
CAGR 10-Years
N/A
|
|
Hikma Pharmaceuticals PLC
LSE:HIK
|
Common Stock
$40m
|
CAGR 3-Years
-1%
|
CAGR 5-Years
0%
|
CAGR 10-Years
1%
|
|
Dechra Pharmaceuticals PLC
LSE:DPH
|
Common Stock
£1.1m
|
CAGR 3-Years
0%
|
CAGR 5-Years
2%
|
CAGR 10-Years
2%
|
See Also
What is AstraZeneca PLC's Common Stock?
Common Stock
388m
USD
Based on the financial report for Mar 31, 2024, AstraZeneca PLC's Common Stock amounts to 388m USD.
What is AstraZeneca PLC's Common Stock growth rate?
Common Stock CAGR 10Y
2%
Over the last year, the Common Stock growth was 0%. The average annual Common Stock growth rates for AstraZeneca PLC have been 6% over the past three years , 4% over the past five years , and 2% over the past ten years .